Delivery Order SPE2D021DA002-SPE2D324F093G
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$1.6K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,602.92 and is for the delivery of the TWINRIX vaccine syringe to military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of the TWINRIX vaccine syringe. The contract has a firm fixed-price pricing type and a completion date of April 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
This firm fixed-price delivery order contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2D program. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes with a completion date of September 20, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the TWINRIX vaccine in syringe form. The delivery order, valued at $1,602.92, is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group Inc. and DLA, contract number SPE2DB-13-D-4600, with a ceiling value of up to $4,999,999 through 2025. This IDC enables DLA to issue firm fixed-price...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,602.92 and covers the delivery of Twinrix vaccine syringes to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order for the TWINRIX vaccine syringe, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $3,903.25 and an ultimate completion date of July 2, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX vaccine in syringe form, with a ceiling value of $24,549.30 and an ultimate completion date of May 28, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...